SNN
Smith & Nephew plc · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -7.7% ·
Aktienfluss +2.9% ·
neue Nettopositionen -8.3%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +1 | 22.17M | $639.71M | +4 | −3 |
| Q1 2026 | 75 | +2 | 19.54M | $620.82M | +5 | −3 |
| Q4 2025 | 73 | 0 | 18.46M | $605.64M | — | — |
| Q3 2025 | 12 | -1 | 6.32M | $229.46M | +1 | −2 |
| Q2 2025 | 10 | +2 | 1.67M | $51.09M | +2 | — |
| Q1 2025 | 6 | 0 | 2.19M | $62.29M | +1 | −1 |
| Q4 2024 | 6 | +1 | 4.19M | $103.01M | +2 | −1 |
| Q3 2024 | 4 | +1 | 214.49K | $6.68M | +1 | — |
| Q2 2024 | 3 | — | 434.31K | $10.76M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Goldman Sachs Group ✦ | 1.95M | — | $70.88M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Goldman Sachs Group ✦ | 1.95M | — | $70.88M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Goldman Sachs Group ✦ | 1.95M | — | $70.88M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.95M | — | $70.83M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 1.95M | — | $70.83M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 1.95M | — | $70.83M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 1.95M | — | $70.83M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 1.95M | — | $70.83M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 1.95M | — | $70.83M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 571.86K | — | $20.75M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 542.79K | +7.5% | $19.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 542.79K | +7.5% | $19.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | BlackRock ✦ (passiv) | 463.24K | +13.8% | $16.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 29 | BlackRock ✦ (passiv) | 463.24K | +13.8% | $16.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | Arrowstreet Capital ✦ | 410.62K | Neu | $14.90M | 0.0% | New | 1 | SEC ↗ |
| 31 | Bridgewater Associates ✦ | 203.99K | +163.8% | $7.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Millennium Management ✦ | 65.73K | -83.9% | $2.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 57.62K | +5.1% | $2.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 55.87K | -15.2% | $2.03M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | State Street Global Advisors ✦ (passiv) | 36.43K | -1.3% | $1.32M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 9.91K | +22.0% | $359,595 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 9.91K | +22.0% | $359,595 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 9.91K | +22.0% | $359,595 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Arrowstreet Capital | $14.90M | 0.0% |
Ausgestiegen
| Renaissance Technologies | $2.95M | war 0.0% |
| Marshall Wace | $261,366 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 2 Inhaber, 515.19K Anteile, $4.73M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.